Encompass Health Corporation (NYSE:EHC) Stock Has Consensus Price Target of $154.25 According to Analysts

Posted by Stanley Muller on Nov 9th, 2026

Shares of Encompass Health Corporation (NYSE:EHC – Get Free Report) have received an average rating of “Buy” from the eight analysts that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $154.25.

EHC has been the subject of a number of research analyst reports. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, October 31st. TD Cowen raised their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Friday, October 30th. Weiss Ratings raised shares of Encompass Health from a “buy (b-)” rating to a “buy (b)” rating in a research note on Thursday, October 8th. Mizuho set a $155.00 target price on shares of Encompass Health in a report on Monday, November 2nd. Finally, Barclays boosted their target price on shares of Encompass Health from $144.00 to $151.00 and gave the stock an “overweight” rating in a report on Thursday, October 29th.

Read Our Latest Analysis on Encompass Health

Encompass Health Price Performance

NYSE EHC opened at $137.50 on Friday. Encompass Health has a 12 month low of $92.77 and a 12 month high of $143.36. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.09 and a quick ratio of 1.09. The firm has a market capitalization of $13.49 billion, a PE ratio of 21.48, a P/E/G ratio of 2.40 and a beta of 0.83. The company’s 50 day simple moving average is $124.70 and its 200 day simple moving average is $110.93.

Encompass Health (NYSE:EHC – Get Free Report) last released its earnings results on Wednesday, October 28th. The company reported $1.52 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.16. Encompass Health had a return on equity of 18.35% and a net margin of 10.17%. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.60 billion. During the same period in the prior year, the firm posted $1.23 earnings per share. The firm’s revenue for the quarter was up 8.9% compared to the same quarter last year. As a group, equities research analysts forecast that Encompass Health will post 6.26 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 15th. Shareholders of record on Monday, January 4th will be given a $0.21 dividend. The ex-dividend date is Monday, January 4th. This represents a $0.84 annualized dividend and a yield of 0.6%. Encompass Health’s payout ratio is 13.12%.

Insider Activity

In other Encompass Health news, EVP John Darby sold 4,858 shares of the company’s stock in a transaction on Monday, August 31st. The stock was sold at an average price of $121.09, for a total value of $588,255.22. Following the transaction, the executive vice president owned 75,041 shares of the company’s stock, valued at approximately $9,086,714.69. This represents a 6.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.80% of the company’s stock.

Hedge Funds Weigh In On Encompass Health

A number of hedge funds have recently added to or reduced their stakes in the company. Transamerica Financial Advisors LLC bought a new stake in Encompass Health in the second quarter worth $29,000. Toth Financial Advisory Corp bought a new position in Encompass Health during the third quarter valued at about $38,000. Persistent Asset Partners Ltd bought a new position in Encompass Health during the second quarter valued at about $36,000. Keating Financial Advisory Services Inc. bought a new position in Encompass Health during the second quarter valued at about $39,000. Finally, Root Financial Partners LLC acquired a new stake in shares of Encompass Health in the third quarter worth about $52,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

About Encompass Health

(Get Free Report)

Encompass Health Corporation is a U.S. healthcare provider focused on inpatient rehabilitation. The company operates rehabilitation hospitals that offer specialized care for people recovering from conditions such as strokes, brain and spinal cord injuries, orthopedic conditions, and other illnesses or injuries.

Its hospitals provide coordinated rehabilitation services, including physical, occupational, and speech therapy, alongside medical care. Encompass Health serves patients through facilities across the United States.

The company was previously known as HealthSouth and adopted the Encompass Health name in 2018.